Who DoseSpot is best for
DoseSpot is an electronic prescribing platform sold mostly to software companies rather than to individual practices. EHR vendors, telehealth and digital health companies, health systems and dental groups license it to add certified e-prescribing to their own products. DoseSpot says more than 50 million prescriptions go through it each year. In March 2026 it merged with Arrive Health, a prescription price transparency company, to form Interra Health, majority owned by Bain Capital Tech Opportunities; DoseSpot continues under its own name.
Best for
- EHR, practice management and telehealth software companies adding e-prescribing
- Digital health and direct-to-consumer telehealth businesses that prescribe at scale
- Dental service organizations and dental practice software vendors
- Solo prescribers without an EHR who need standalone e-prescribing (via TreatRx)
Not ideal for
- Practices wanting a full EHR with e-prescribing built in
- Buyers who want published, self-serve pricing
DoseSpot pros and cons
Pros
- Three integration paths: Full Integration (140+ APIs), Jumpstart (a plug-and-play UI, which DoseSpot says can go live in 30 days) and standalone TreatRx
- EPCS certified by Drummond, with Surescripts certification
- Electronic prior authorization and real-time prescription benefit checks at the point of prescribing
- Patient-facing price and affordability tools through DoseSpot Connect
- SOC 2 Type II and HITRUST certification stated by the vendor
Cons
- No published pricing for any product
- Clinicians rarely buy directly, so support often runs through the software vendor that embedded it
- Integration partners are not named publicly
- Ownership and branding are in transition after the Interra Health merger
DoseSpot pricing
DoseSpot does not publish pricing as of October 2026. Software partners negotiate licensing, which usually depends on integration type (Full Integration or Jumpstart), number of prescribers and add-ons such as EPCS, ePA and RTPB. TreatRx is sold as a monthly subscription that DoseSpot says has no setup fees and can be cancelled anytime, with EPCS available as an upgrade; prices sit behind a sign-up flow. If you use DoseSpot inside an EHR or telehealth product, the cost is set by that vendor.
Key features
- Core ePrescribing: new prescriptions, renewals, refill requests, pharmacy routing, drug and allergy alerts, and medication history
- EPCS: electronic prescribing of controlled substances
- Electronic Prior Authorization (ePA): submit and appeal prior authorizations in the prescribing workflow
- Real-Time Prescription Benefit (RTPB): patient-specific cost and covered alternatives while prescribing
- DoseSpot Connect: patient engagement for medication affordability and adherence
- Full Integration and Jumpstart: the two ways software partners embed DoseSpot
- TreatRx: standalone web-based e-prescribing for providers without an EHR, acquired from Bravado Health in 2023
- Total DoseSpot Solution: e-prescribing bundled with revenue cycle tools from pVerify, an eligibility vendor DoseSpot acquired in 2023
HIPAA, security and integrations
DoseSpot states it holds SOC 2 Type II and HITRUST certification, is Drummond-certified for controlled substances, follows NCPDP standards and is certified by Surescripts. It handles PHI as a business associate of its partners and customers; request a BAA through your contract. It also lists ONC certification and links to a trust portal from its site. DoseSpot does not list its integration partners publicly; it describes itself as embedded in EHR, telehealth, digital health and dental platforms, with 140+ APIs for Full Integration and up to 70 for Jumpstart.
DoseSpot alternatives
- DrFirst — e-prescribing and medication management sold both to EHR vendors and to hospitals and practices.
- Ensora eRx (formerly NewCrop) — another embeddable e-prescribing engine long used by EHR vendors.
- RXNT eRx — standalone e-prescribing with published pricing for individual practices.
- MDToolbox — low-cost standalone e-prescribing for small practices.
